<DOC>
	<DOCNO>NCT01430052</DOCNO>
	<brief_summary>The purpose study evaluate clinical effectiveness Gemcitabine/S-1 combination chemoradiotherapy Gemcitabine /S-1 combination chemotherapy unresectable locally advanced pancreatic cancer .</brief_summary>
	<brief_title>Chemoradiotherapy With Gemcitabine/S-1 v Gemcitabine/S-1 Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description>When cancer develop outside pancreas within anatomical placement pancreas , become difficult excise case . Generally , pancreatic cancer already unresectable time diagnosis recognize infiltration 1/2 circumference major artery celiac artery super mesenteric artery particular . In comparison advance pancreatic cancer distant metastasis , easy treat unresectable locally advanced pancreatic cancer , even perform standard gemcitabine monotherapy . In case unresectable locally advanced pancreatic cancer without distant metastasis , leave choice whether perform radiation therapy . This decision remain unsolved worldwide , despite continue effort researcher bring end clinical doubt . We report result well problem combine treatment chemoradiotherapy , use novel anticancer agent gemcitabine well as/or S-1 , 5FU , predominantly clinical trial occasion .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>1 . Histologically cytologically confirm adenocarcinoma , adenocarcinoma squamous carcinoma pancreatic cancer . 2 . Patients confirm unresectable locally advanced pancreatic cancer criterion . Involving 1/2 circumference major artery ( SMA/CA ) . ( Under 1/2 borderline lesion . ) Involving merge section portalSMV . No distal metastasis diagnostic imaging . Confirmed CT image perform four week registration . 3 . Performance Status:01 ( ECOG ) 4 . Patients age = &gt; 20 80 &gt; 5. sufficient organ function neutrophil &gt; =1,500/mm3 platelet &gt; =100,000/mm3 hemoglobin &gt; =9.0g/dl AST ( GOT ) /ALT ( GPT ) &lt; =150IU total bilirubin &lt; =2.0mg/dl , ( &lt; =3.0mg/dl biliary drainage present ) serum creatinine &lt; = 1.2mg/dl creatinine clearance &gt; =60ml/min 6 . Life expectancy 3 month . 7 . Written informed consent . 1 . Lung fibrosis intestinal pneumonia , anamnesis imaging finding . 2 . Watery diarrhea 3 . Severe infection 4 . Severe complication ( heart failure , renal failure , hepatic insufficiency , hemorrhagic peptic ulcer , intestines paralysis , ileus uncontrolled diabetes etc ) 5 . Massive pleural abdominal effusion . 6 . Metastasis central nervous system . 7 . Active synchronous metachronous malignancy carcinoma situ . 8 . Regular use flucytosine , fenitoin warfarin 9 . Pregnant lactation woman , woman know suspected pregnancy men want let pregnancy 10 . Severe mental illness 11 . Patients judge inappropriate entry study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>